AIM: To explore the role of the adaptor molecule in liver regeneration after partial hepatectomy (PH). METHODS: We used transgenic mice expressing an N-terminal truncated form of MORT1/FADD under the control of the albumin promoter. As previously shown, this transgenic protein abrogated CD95- and CD120a-mediated apoptosis in the liver. Cyclin A expression was detected using Western blotting. ELISA and RT-PCR were used to detect IL-6 and IL-6 mRNA, respectively. DNA synthesis in liver tissue was measured by BrdU staining. RESULTS: Resection of 70% of the liver was followed by a reduced early regenerative response in the transgenic group at 36 h. Accordingly, 36 h after hepatectomy, cyclin A expression was only detectable in wild-type animals. Consequently, the onset of liver mass restoration was retarded as measured by MRI volumetry and mortality was significantly higher in the transgenic group. CONCLUSION: Our data demonstrate for the first time an involvement of the death receptor molecule MORT1/FADD in liver regeneration, beyond its well described role as part of the intracellular death signaling pathway.
AIM: To explore the role of the adaptor molecule in liver regeneration after partial hepatectomy (PH). METHODS: We used transgenic mice expressing an N-terminal truncated form of MORT1/FADD under the control of the albumin promoter. As previously shown, this transgenic protein abrogated CD95- and CD120a-mediated apoptosis in the liver. Cyclin A expression was detected using Western blotting. ELISA and RT-PCR were used to detect IL-6 and IL-6 mRNA, respectively. DNA synthesis in liver tissue was measured by BrdU staining. RESULTS: Resection of 70% of the liver was followed by a reduced early regenerative response in the transgenic group at 36 h. Accordingly, 36 h after hepatectomy, cyclin A expression was only detectable in wild-type animals. Consequently, the onset of liver mass restoration was retarded as measured by MRI volumetry and mortality was significantly higher in the transgenic group. CONCLUSION: Our data demonstrate for the first time an involvement of the death receptor molecule MORT1/FADD in liver regeneration, beyond its well described role as part of the intracellular death signaling pathway.
Authors: W C Yeh; A Itie; A J Elia; M Ng; H B Shu; A Wakeham; C Mirtsos; N Suzuki; M Bonnard; D V Goeddel; T W Mak Journal: Immunity Date: 2000-06 Impact factor: 31.745
Authors: T Kataoka; R C Budd; N Holler; M Thome; F Martinon; M Irmler; K Burns; M Hahne; N Kennedy; M Kovacsovics; J Tschopp Journal: Curr Biol Date: 2000-06-01 Impact factor: 10.834
Authors: Y Iimuro; T Nishiura; C Hellerbrand; K E Behrns; R Schoonhoven; J W Grisham; D A Brenner Journal: J Clin Invest Date: 1998-02-15 Impact factor: 14.808
Authors: W C Yeh; J L de la Pompa; M E McCurrach; H B Shu; A J Elia; A Shahinian; M Ng; A Wakeham; W Khoo; K Mitchell; W S El-Deiry; S W Lowe; D V Goeddel; T W Mak Journal: Science Date: 1998-03-20 Impact factor: 47.728
Authors: Jörn M Schattenberg; Marcus A Wörns; Tim Zimmermann; You-Wen He; Peter R Galle; Marcus Schuchmann Journal: Free Radic Biol Med Date: 2012-03-08 Impact factor: 7.376
Authors: Binje Vick; Achim Weber; Toni Urbanik; Thorsten Maass; Andreas Teufel; Peter H Krammer; Joseph T Opferman; Marcus Schuchmann; Peter R Galle; Henning Schulze-Bergkamen Journal: Hepatology Date: 2009-02 Impact factor: 17.425